Sagent Pharmaceuticals, Inc. (SGNT) Posts Q3 Loss of $0.17, Sales Top Expectations

Go back to Sagent Pharmaceuticals, Inc. (SGNT) Posts Q3 Loss of $0.17, Sales Top Expectations